However, also other cannabinoids, such as cannabidiolic acid (CBDA) and tetrahydrocannabinolic acid (THCA), have also been shown to reduce Aβ and tau pathology in a murine Alzheimer’s disease model [35]. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.